Try our beta test site
33 studies found for:    Open Studies | "Hypotrichosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan
Condition: Eyelash Hypotrichosis
Intervention: Drug: Bimatoprost cutaneous solution 0.03%
2 Recruiting Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females
Condition: Hair Loss
Interventions: Dietary Supplement: Nutrafol;   Dietary Supplement: placebo
3 Recruiting The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: Platelet Rich Plasma Prep System;   Drug: Placebo
4 Recruiting Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
Condition: Alopecia, Androgenetic
Interventions: Drug: P-3074;   Drug: Finasteride;   Drug: Vehicle
5 Recruiting Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: PF-06651600;   Drug: PF-06700841;   Drug: Placebo
6 Recruiting Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
Condition: Alopecia
Interventions: Drug: CG 428 cutaneous solution;   Drug: Placebo cutaneous solution
7 Not yet recruiting Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
Condition: Hair Restoration Using Autologous Mesenchymal Stem Cells
Interventions: Drug: stem cells;   Drug: platelet rich plasma
8 Recruiting Hairstetics Hair Implant Device Safety and Efficacy
Condition: Alopecia
Intervention: Device: Hairstetics hair implant device
9 Not yet recruiting Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
Condition: Androgenic Alopecia
Interventions: Drug: DA-4001 H;   Drug: DA-4001 L
10 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
11 Recruiting Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Condition: Alopecia
Interventions: Drug: setipiprant;   Drug: placebo;   Drug: finasteride
12 Recruiting Point-of-Care Adipose-derived Cells for Hair Growth
Condition: Androgenetic Alopecia
Interventions: Procedure: Stromal Vascular Fraction Cells (SVF Cells) Injection;   Procedure: Liposuction;   Other: Hair Measurements
13 Recruiting Topical Garlic Concentrate for Alopecia Areata in Children
Condition: Alopecia Areata
Intervention: Drug: garlic concentrate
14 Recruiting Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Apremilast;   Drug: Placebo
15 Recruiting A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Tralokinumab;   Drug: Placebo
16 Recruiting Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Conditions: Alopecia;   Alopecia, Androgenetic;   Baldness
Intervention: Drug: Bimatoprost
17 Not yet recruiting Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: SHAPE Gel
18 Recruiting Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
Condition: Alopecia Areata
Intervention: Other: MEXIS/M6S Patent - lotion against alopecia
19 Not yet recruiting Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment
Condition: Androgenetic Alopecia
Interventions: Device: Autologous Platelet Rich Plasma;   Device: Saline solution injection
20 Recruiting TREg Activation in the Treatment of the PELADE (Alopecia Areata)
Condition: Alopecia Areata
Interventions: Drug: IL2;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.